Thiotepa

Generic Name
Thiotepa
Brand Names
Tepadina, Thiotepa Riemser
Drug Type
Small Molecule
Chemical Formula
C6H12N3PS
CAS Number
52-24-4
Unique Ingredient Identifier
905Z5W3GKH
Background

N,N'N'-triethylenethiophosphoramide (ThioTEPA) is a cancer chemotherapeutic member of the alkylating agent group, now in use for over 50 years. It is a stable derivative of N,N',N''- triethylenephosphoramide (TEPA). It is mostly used to treat breast cancer, ovarian cancer and bladder cancer. It is also used as conditioning for Bone marrow transplantation. It...

Indication

ThioTEPA is used a as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (HPCT) in haematological diseases in adult and paediatric patients. Also, when high dose chemotherapy with HPCT support it is appropriate for the treatment of solid tumours in adult and paediatric patients.

Associated Conditions
Adenocarcinoma of the Ovaries, Breast Adenocarcinoma, Papillary transitional cell carcinoma of bladder, Malignant effusion
Associated Therapies
-
Clinical Trials
Related News

Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Infants With Malignant Brain or Spinal Cord Tumors

First Posted Date
2003-11-06
Last Posted Date
2014-03-28
Lead Sponsor
Children's Oncology Group
Target Recruit Count
94
Registration Number
NCT00003141
Locations
🇺🇸

Childrens Hospital Los Angeles, Los Angeles, California, United States

🇺🇸

Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States

🇺🇸

Children's Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania, United States

and more 68 locations

Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Neuroblastoma

First Posted Date
2003-10-09
Last Posted Date
2014-02-13
Lead Sponsor
Children's Oncology Group
Target Recruit Count
42
Registration Number
NCT00017368
Locations
🇺🇸

CCOP - Columbia River Oncology Program, Portland, Oregon, United States

🇺🇸

Floating Hospital for Children, Boston, Massachusetts, United States

🇺🇸

CCOP - Marshfield Clinic Research Foundation, Marshfield, Wisconsin, United States

and more 6 locations

Randomized Double Cord Blood Transplant Study

First Posted Date
2003-08-11
Last Posted Date
2019-05-01
Lead Sponsor
M.D. Anderson Cancer Center
Target Recruit Count
110
Registration Number
NCT00067002
Locations
🇺🇸

University of Texas MD Anderson Cancer Center, Houston, Texas, United States

Peripheral Stem Cell Transplant in Treating Patients With High-Risk Leukemia

First Posted Date
2003-08-07
Last Posted Date
2013-05-01
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Target Recruit Count
51
Registration Number
NCT00066417
Locations
🇺🇸

NIH - Warren Grant Magnuson Clinical Center, Bethesda, Maryland, United States

Comparison of Biological Therapies Following Combination Chemotherapy and Bone Marrow or Peripheral Stem Cell Transplantation in Women With Stage II or Stage III Breast Cancer

Phase 3
Completed
Conditions
Breast Cancer
First Posted Date
2003-06-05
Last Posted Date
2013-02-04
Lead Sponsor
Herbert Irving Comprehensive Cancer Center
Registration Number
NCT00008203
Locations
🇺🇸

Herbert Irving Comprehensive Cancer Center, New York, New York, United States

High-Dose Chemotherapy, Total-Body Irradiation, and Autologous Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Hematologic Cancer or Solid Tumors

First Posted Date
2003-05-07
Last Posted Date
2013-05-09
Lead Sponsor
Roswell Park Cancer Institute
Target Recruit Count
451
Registration Number
NCT00060255
Locations
🇺🇸

Roswell Park Cancer Institute, Buffalo, New York, United States

Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid Tumors

First Posted Date
2003-05-02
Last Posted Date
2017-11-29
Lead Sponsor
Masonic Cancer Center, University of Minnesota
Target Recruit Count
13
Registration Number
NCT00003926
Locations
🇺🇸

University of Minnesota Cancer Center, Minneapolis, Minnesota, United States

High-Dose Thiotepa Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory Solid Tumors

First Posted Date
2003-04-23
Last Posted Date
2013-03-07
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
36
Registration Number
NCT00003173
Locations
🇺🇸

NYU School of Medicine's Kaplan Comprehensive Cancer Center, New York, New York, United States

🇺🇸

Memorial Sloan-Kettering Cancer Center, New York, New York, United States

Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Persistent Epithelial Ovarian Cancer, Fallopian Tube, or Primary Peritoneal Cancer

First Posted Date
2003-04-18
Last Posted Date
2014-01-06
Lead Sponsor
Herbert Irving Comprehensive Cancer Center
Target Recruit Count
30
Registration Number
NCT00003064
Locations
🇺🇸

Herbert Irving Comprehensive Cancer Center, New York, New York, United States

Chemotherapy, Surgery, Radiation Therapy and Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Primary CNS Germ Cell Tumors

First Posted Date
2003-01-27
Last Posted Date
2013-12-18
Lead Sponsor
Children's Hospital Los Angeles
Registration Number
NCT00025324
Locations
🇺🇸

Children's Hospital of the King's Daughters, Norfolk, Virginia, United States

🇨🇦

Tom Baker Cancer Centre - Calgary, Calgary, Alberta, Canada

🇺🇸

Children's Hospital Los Angeles, Los Angeles, California, United States

and more 1 locations
© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy